ANDA 203660, held by Epic Pharma LLC. Azelastine Hydrochloride.
As of Nov 16, 2026, ANDA 203660 (Azelastine Hydrochloride), held by Epic Pharma LLC, was first approved by FDA on Nov 8, 2016, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 8, 2016 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Azelastine Hydrochloride0.05% ยท solution/drops;ophthalmic | Azelastine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters